CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
24 hedge funds and large institutions have $2.65M invested in CASI Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less capital invested
Capital invested by funds: $5.93M → $2.65M (-$3.28M)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66.4K | |
| 2 | +$22K | |
| 3 | +$21.3K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$2.34K |
| 5 |
Renaissance Technologies
New York
|
+$550 |
Top Sellers
| 1 | -$994K | |
| 2 | -$20.1K | |
| 3 | -$6.05K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.91K |
| 5 |
Morgan Stanley
New York
|
-$2.06K |